These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37484373)

  • 21. Cell Metabolomics Reveals the Potential Mechanism of Aloe Emodin and Emodin Inhibiting Breast Cancer Metastasis.
    Cheng G; Liu Z; Zheng Z; Song F; Zhuang X; Liu S
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aloe emodin suppresses EGF‑induced neoplastic cell transformation by inhibiting the ERK/MSK1 and AKT/GSK3β signaling pathways.
    Zhang J; Guo L; Zhang Q; Liu K; Dong Z
    Mol Med Rep; 2018 Dec; 18(6):5215-5220. PubMed ID: 30272294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways.
    Yue SJ; Zhang PX; Zhu Y; Li NG; Chen YY; Li JJ; Zhang S; Jin RY; Yan H; Shi XQ; Tang YP; Duan JA
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31181779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Berberine and Emodin abrogates breast cancer growth and facilitates apoptosis through inactivation of SIK3-induced mTOR and Akt signaling pathway.
    Ponnusamy L; Kothandan G; Manoharan R
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165897. PubMed ID: 32682817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway.
    Chu H; Du C; Yang Y; Feng X; Zhu L; Chen J; Yang F
    Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
    Dai W; Xiang W; Han L; Yuan Z; Wang R; Ma Y; Yang Y; Cai S; Xu Y; Mo S; Li Q; Cai G
    Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emodin Inhibits Breast Cancer Growth by Blocking the Tumor-Promoting Feedforward Loop between Cancer Cells and Macrophages.
    Iwanowycz S; Wang J; Hodge J; Wang Y; Yu F; Fan D
    Mol Cancer Ther; 2016 Aug; 15(8):1931-42. PubMed ID: 27196773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of PI3K/Akt, ERK and p38 signaling pathways in emodin-mediated extrinsic and intrinsic human hepatoblastoma cell apoptosis.
    Cui Y; Lu P; Song G; Liu Q; Zhu D; Liu X
    Food Chem Toxicol; 2016 Jun; 92():26-37. PubMed ID: 27032576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer.
    Tang Q; Wu J; Zheng F; Hann SS; Chen Y
    Cell Physiol Biochem; 2017; 41(1):339-357. PubMed ID: 28214826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emodin improves lipid and glucose metabolism in high fat diet-induced obese mice through regulating SREBP pathway.
    Li J; Ding L; Song B; Xiao X; Qi M; Yang Q; Yang Q; Tang X; Wang Z; Yang L
    Eur J Pharmacol; 2016 Jan; 770():99-109. PubMed ID: 26626587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3
    Lu J; Xu Y; Wei X; Zhao Z; Xue J; Liu P
    Biomed Res Int; 2016; 2016():6253280. PubMed ID: 28097141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stearoyl-CoA desaturase 1 regulates malignant progression of cervical cancer cells.
    Wang L; Ye G; Wang Y; Wang C
    Bioengineered; 2022 May; 13(5):12941-12954. PubMed ID: 35609330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emodin Improves Glucose and Lipid Metabolism Disorders in Obese Mice
    Cheng L; Zhang S; Shang F; Ning Y; Huang Z; He R; Sun J; Dong S
    Front Endocrinol (Lausanne); 2021; 12():618037. PubMed ID: 34040579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
    Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
    Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emodin, a Naturally Occurring Anthraquinone Derivative, Ameliorates Dyslipidemia by Activating AMP-Activated Protein Kinase in High-Fat-Diet-Fed Rats.
    Tzeng TF; Lu HJ; Liou SS; Chang CJ; Liu IM
    Evid Based Complement Alternat Med; 2012; 2012():781812. PubMed ID: 22649478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
    Tanahashi T; Osada S; Yamada A; Kato J; Yawata K; Mori R; Imai H; Sasaki Y; Saito S; Tanaka Y; Nonaka K; Yoshida K
    Int J Oncol; 2013 Feb; 42(2):556-64. PubMed ID: 23229794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anthraquinone derivative Emodin inhibits angiogenesis and metastasis through downregulating Runx2 activity in breast cancer.
    Ma J; Lu H; Wang S; Chen B; Liu Z; Ke X; Liu T; Fu J
    Int J Oncol; 2015 Apr; 46(4):1619-28. PubMed ID: 25673059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
    Thacker PC; Karunagaran D
    PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
    Liu G; Kuang S; Cao R; Wang J; Peng Q; Sun C
    FASEB J; 2019 Sep; 33(9):10089-10103. PubMed ID: 31199678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.